Latest News and Press Releases
Want to stay updated on the latest news?
-
CAMBRIDGE, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
-
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reiterated its "I4 2012" goals and...
-
CAMBRIDGE, Mass., Feb. 9, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the presentation of...
-
CAMBRIDGE, Mass., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Infinity management...
-
Begins 2009 With Four Years of Capital, Three Clinical Candidates in Development, Two New INDs, and One Pivotal Trial Introduces "I4 2012" Long-Term Goals CAMBRIDGE,...
-
CAMBRIDGE, Mass., Jan. 8, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced that its shareholders have voted...
-
CAMBRIDGE, Mass., Jan. 6, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman,...
-
Infinity to Independently Develop Its Industry-Leading Hsp90 Program Clinical Programs Continue to Advance On Schedule CAMBRIDGE, Mass., Dec. 11, 2008 (GLOBE NEWSWIRE) -- Infinity...
-
CAMBRIDGE, Mass., Nov. 26, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins,...
-
Infinity Retains All U.S. Rights; Mundipharma Receives Ex-U.S. Commercialization Rights to All Oncology Products Under Alliance Infinity to Receive Up to $75 Million Equity...